| Name | Title | Contact Details |
|---|---|---|
Shikha Barman |
Chief Technology Officer | Profile |
Princeton Separations Inc is a Freehold, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Verinata Health is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OriGene Technologies is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Spinemark is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products geared towards addressing unmet needs and providing unique and meaningful advantages to patients with renal disease and their healthcare providers. Patients have been and continue to be at the center of our 16-year corporate history. Keryx is headquartered in New York City, and recently expanded its footprint to Boston, the country’s life sciences hub, to support the US launch of Auryxia™ (ferric citrate). Several functions are housed in the company’s Boston office, including commercial, regulatory, medical affairs, as well as many general and administrative functions. Joining Boston’s pioneering biotech community has given us the opportunity to bring together a seasoned talent pool of innovative minds and resources that will allow us to continue toward our goal of building a top-notch commercial organization. We are a rapidly growing company, with approximately 90 full-time employees across New York, Boston and our field team, with the expectation to grow to approximately 150 in the coming months with the addition of field sales representatives.